1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Diabetic Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Sulphonylureas 1.2.3 Biguanides 1.2.4 Meglitinides 1.2.5 Thiazolidinediones 1.2.6 Alpha-glucosidase Inhibitors 1.2.7 DPP-4 Inhibitors 1.2.8 SGLT-2 Inhibitors 1.3 Market by Application 1.3.1 Global Diabetic Therapeutic Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Diagnostic/Clinics 1.3.3 ICUs 1.3.4 Home Healthcare 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Diabetic Therapeutic Market Perspective (2016-2027) 2.2 Diabetic Therapeutic Growth Trends by Regions 2.2.1 Diabetic Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Diabetic Therapeutic Historic Market Share by Regions (2016-2021) 2.2.3 Diabetic Therapeutic Forecasted Market Size by Regions (2022-2027) 2.3 Diabetic Therapeutic Industry Dynamic 2.3.1 Diabetic Therapeutic Market Trends 2.3.2 Diabetic Therapeutic Market Drivers 2.3.3 Diabetic Therapeutic Market Challenges 2.3.4 Diabetic Therapeutic Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Diabetic Therapeutic Players by Revenue 3.1.1 Global Top Diabetic Therapeutic Players by Revenue (2016-2021) 3.1.2 Global Diabetic Therapeutic Revenue Market Share by Players (2016-2021) 3.2 Global Diabetic Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Diabetic Therapeutic Revenue 3.4 Global Diabetic Therapeutic Market Concentration Ratio 3.4.1 Global Diabetic Therapeutic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Diabetic Therapeutic Revenue in 2020 3.5 Diabetic Therapeutic Key Players Head office and Area Served 3.6 Key Players Diabetic Therapeutic Product Solution and Service 3.7 Date of Enter into Diabetic Therapeutic Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Diabetic Therapeutic Breakdown Data by Type 4.1 Global Diabetic Therapeutic Historic Market Size by Type (2016-2021) 4.2 Global Diabetic Therapeutic Forecasted Market Size by Type (2022-2027) 5 Diabetic Therapeutic Breakdown Data by Application 5.1 Global Diabetic Therapeutic Historic Market Size by Application (2016-2021) 5.2 Global Diabetic Therapeutic Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Diabetic Therapeutic Market Size (2016-2027) 6.2 North America Diabetic Therapeutic Market Size by Type 6.2.1 North America Diabetic Therapeutic Market Size by Type (2016-2021) 6.2.2 North America Diabetic Therapeutic Market Size by Type (2022-2027) 6.2.3 North America Diabetic Therapeutic Market Size by Type (2016-2027) 6.3 North America Diabetic Therapeutic Market Size by Application 6.3.1 North America Diabetic Therapeutic Market Size by Application (2016-2021) 6.3.2 North America Diabetic Therapeutic Market Size by Application (2022-2027) 6.3.3 North America Diabetic Therapeutic Market Size by Application (2016-2027) 6.4 North America Diabetic Therapeutic Market Size by Country 6.4.1 North America Diabetic Therapeutic Market Size by Country (2016-2021) 6.4.2 North America Diabetic Therapeutic Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Diabetic Therapeutic Market Size (2016-2027) 7.2 Europe Diabetic Therapeutic Market Size by Type 7.2.1 Europe Diabetic Therapeutic Market Size by Type (2016-2021) 7.2.2 Europe Diabetic Therapeutic Market Size by Type (2022-2027) 7.2.3 Europe Diabetic Therapeutic Market Size by Type (2016-2027) 7.3 Europe Diabetic Therapeutic Market Size by Application 7.3.1 Europe Diabetic Therapeutic Market Size by Application (2016-2021) 7.3.2 Europe Diabetic Therapeutic Market Size by Application (2022-2027) 7.3.3 Europe Diabetic Therapeutic Market Size by Application (2016-2027) 7.4 Europe Diabetic Therapeutic Market Size by Country 7.4.1 Europe Diabetic Therapeutic Market Size by Country (2016-2021) 7.4.2 Europe Diabetic Therapeutic Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Diabetic Therapeutic Market Size (2016-2027) 8.2 Asia-Pacific Diabetic Therapeutic Market Size by Type 8.2.1 Asia-Pacific Diabetic Therapeutic Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Diabetic Therapeutic Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Diabetic Therapeutic Market Size by Type (2016-2027) 8.3 Asia-Pacific Diabetic Therapeutic Market Size by Application 8.3.1 Asia-Pacific Diabetic Therapeutic Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Diabetic Therapeutic Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Diabetic Therapeutic Market Size by Application (2016-2027) 8.4 Asia-Pacific Diabetic Therapeutic Market Size by Region 8.4.1 Asia-Pacific Diabetic Therapeutic Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Diabetic Therapeutic Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Diabetic Therapeutic Market Size (2016-2027) 9.2 Latin America Diabetic Therapeutic Market Size by Type 9.2.1 Latin America Diabetic Therapeutic Market Size by Type (2016-2021) 9.2.2 Latin America Diabetic Therapeutic Market Size by Type (2022-2027) 9.2.3 Latin America Diabetic Therapeutic Market Size by Type (2016-2027) 9.3 Latin America Diabetic Therapeutic Market Size by Application 9.3.1 Latin America Diabetic Therapeutic Market Size by Application (2016-2021) 9.3.2 Latin America Diabetic Therapeutic Market Size by Application (2022-2027) 9.3.3 Latin America Diabetic Therapeutic Market Size by Application (2016-2027) 9.4 Latin America Diabetic Therapeutic Market Size by Country 9.4.1 Latin America Diabetic Therapeutic Market Size by Country (2016-2021) 9.4.2 Latin America Diabetic Therapeutic Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Diabetic Therapeutic Market Size (2016-2027) 10.2 Middle East & Africa Diabetic Therapeutic Market Size by Type 10.2.1 Middle East & Africa Diabetic Therapeutic Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Diabetic Therapeutic Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Diabetic Therapeutic Market Size by Type (2016-2027) 10.3 Middle East & Africa Diabetic Therapeutic Market Size by Application 10.3.1 Middle East & Africa Diabetic Therapeutic Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Diabetic Therapeutic Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Diabetic Therapeutic Market Size by Application (2016-2027) 10.4 Middle East & Africa Diabetic Therapeutic Market Size by Country 10.4.1 Middle East & Africa Diabetic Therapeutic Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Diabetic Therapeutic Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Diabetic Therapeutic Introduction 11.1.4 Sanofi Revenue in Diabetic Therapeutic Business (2016-2021) 11.1.5 Sanofi Recent Development 11.2 Novo Nordisk 11.2.1 Novo Nordisk Company Details 11.2.2 Novo Nordisk Business Overview 11.2.3 Novo Nordisk Diabetic Therapeutic Introduction 11.2.4 Novo Nordisk Revenue in Diabetic Therapeutic Business (2016-2021) 11.2.5 Novo Nordisk Recent Development 11.3 MSD 11.3.1 MSD Company Details 11.3.2 MSD Business Overview 11.3.3 MSD Diabetic Therapeutic Introduction 11.3.4 MSD Revenue in Diabetic Therapeutic Business (2016-2021) 11.3.5 MSD Recent Development 11.4 Astrazeneca 11.4.1 Astrazeneca Company Details 11.4.2 Astrazeneca Business Overview 11.4.3 Astrazeneca Diabetic Therapeutic Introduction 11.4.4 Astrazeneca Revenue in Diabetic Therapeutic Business (2016-2021) 11.4.5 Astrazeneca Recent Development 11.5 Takeda 11.5.1 Takeda Company Details 11.5.2 Takeda Business Overview 11.5.3 Takeda Diabetic Therapeutic Introduction 11.5.4 Takeda Revenue in Diabetic Therapeutic Business (2016-2021) 11.5.5 Takeda Recent Development 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Diabetic Therapeutic Introduction 11.6.4 Novartis Revenue in Diabetic Therapeutic Business (2016-2021) 11.6.5 Novartis Recent Development 11.7 AbbVie 11.7.1 AbbVie Company Details 11.7.2 AbbVie Business Overview 11.7.3 AbbVie Diabetic Therapeutic Introduction 11.7.4 AbbVie Revenue in Diabetic Therapeutic Business (2016-2021) 11.7.5 AbbVie Recent Development 11.8 Eli Lilly 11.8.1 Eli Lilly Company Details 11.8.2 Eli Lilly Business Overview 11.8.3 Eli Lilly Diabetic Therapeutic Introduction 11.8.4 Eli Lilly Revenue in Diabetic Therapeutic Business (2016-2021) 11.8.5 Eli Lilly Recent Development 11.9 North China Pharmaceutical Group Corporation 11.9.1 North China Pharmaceutical Group Corporation Company Details 11.9.2 North China Pharmaceutical Group Corporation Business Overview 11.9.3 North China Pharmaceutical Group Corporation Diabetic Therapeutic Introduction 11.9.4 North China Pharmaceutical Group Corporation Revenue in Diabetic Therapeutic Business (2016-2021) 11.9.5 North China Pharmaceutical Group Corporation Recent Development 11.10 Huadong Medicine 11.10.1 Huadong Medicine Company Details 11.10.2 Huadong Medicine Business Overview 11.10.3 Huadong Medicine Diabetic Therapeutic Introduction 11.10.4 Huadong Medicine Revenue in Diabetic Therapeutic Business (2016-2021) 11.10.5 Huadong Medicine Recent Development 11.11 Dongbao Pharmaceutical 11.11.1 Dongbao Pharmaceutical Company Details 11.11.2 Dongbao Pharmaceutical Business Overview 11.11.3 Dongbao Pharmaceutical Diabetic Therapeutic Introduction 11.11.4 Dongbao Pharmaceutical Revenue in Diabetic Therapeutic Business (2016-2021) 11.11.5 Dongbao Pharmaceutical Recent Development 11.12 Hisun Pharmacy 11.12.1 Hisun Pharmacy Company Details 11.12.2 Hisun Pharmacy Business Overview 11.12.3 Hisun Pharmacy Diabetic Therapeutic Introduction 11.12.4 Hisun Pharmacy Revenue in Diabetic Therapeutic Business (2016-2021) 11.12.5 Hisun Pharmacy Recent Development 11.13 KELUN 11.13.1 KELUN Company Details 11.13.2 KELUN Business Overview 11.13.3 KELUN Diabetic Therapeutic Introduction 11.13.4 KELUN Revenue in Diabetic Therapeutic Business (2016-2021) 11.13.5 KELUN Recent Development 11.14 Ginwa 11.14.1 Ginwa Company Details 11.14.2 Ginwa Business Overview 11.14.3 Ginwa Diabetic Therapeutic Introduction 11.14.4 Ginwa Revenue in Diabetic Therapeutic Business (2016-2021) 11.14.5 Ginwa Recent Development 11.15 Tianan Pharmaceutical 11.15.1 Tianan Pharmaceutical Company Details 11.15.2 Tianan Pharmaceutical Business Overview 11.15.3 Tianan Pharmaceutical Diabetic Therapeutic Introduction 11.15.4 Tianan Pharmaceutical Revenue in Diabetic Therapeutic Business (2016-2021) 11.15.5 Tianan Pharmaceutical Recent Development 11.16 Jumpcan Pharmacy 11.16.1 Jumpcan Pharmacy Company Details 11.16.2 Jumpcan Pharmacy Business Overview 11.16.3 Jumpcan Pharmacy Diabetic Therapeutic Introduction 11.16.4 Jumpcan Pharmacy Revenue in Diabetic Therapeutic Business (2016-2021) 11.16.5 Jumpcan Pharmacy Recent Development 11.17 Guangzhou Baiyun Mountain 11.17.1 Guangzhou Baiyun Mountain Company Details 11.17.2 Guangzhou Baiyun Mountain Business Overview 11.17.3 Guangzhou Baiyun Mountain Diabetic Therapeutic Introduction 11.17.4 Guangzhou Baiyun Mountain Revenue in Diabetic Therapeutic Business (2016-2021) 11.17.5 Guangzhou Baiyun Mountain Recent Development 11.18 SHIJIAZHUANG YILING PHARMACEUTICAL 11.18.1 SHIJIAZHUANG YILING PHARMACEUTICAL Company Details 11.18.2 SHIJIAZHUANG YILING PHARMACEUTICAL Business Overview 11.18.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetic Therapeutic Introduction 11.18.4 SHIJIAZHUANG YILING PHARMACEUTICAL Revenue in Diabetic Therapeutic Business (2016-2021) 11.18.5 SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development 11.19 Wanbang Biopharmaceuticals 11.19.1 Wanbang Biopharmaceuticals Company Details 11.19.2 Wanbang Biopharmaceuticals Business Overview 11.19.3 Wanbang Biopharmaceuticals Diabetic Therapeutic Introduction 11.19.4 Wanbang Biopharmaceuticals Revenue in Diabetic Therapeutic Business (2016-2021) 11.19.5 Wanbang Biopharmaceuticals Recent Development 11.20 Gan & Lee 11.20.1 Gan & Lee Company Details 11.20.2 Gan & Lee Business Overview 11.20.3 Gan & Lee Diabetic Therapeutic Introduction 11.20.4 Gan & Lee Revenue in Diabetic Therapeutic Business (2016-2021) 11.20.5 Gan & Lee Recent Development 11.21 Taloph 11.21.1 Taloph Company Details 11.21.2 Taloph Business Overview 11.21.3 Taloph Diabetic Therapeutic Introduction 11.21.4 Taloph Revenue in Diabetic Therapeutic Business (2016-2021) 11.21.5 Taloph Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Diabetic Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Sulphonylureas Table 3. Key Players of Biguanides Table 4. Key Players of Meglitinides Table 5. Key Players of Thiazolidinediones Table 6. Key Players of Alpha-glucosidase Inhibitors Table 7. Key Players of DPP-4 Inhibitors Table 8. Key Players of SGLT-2 Inhibitors Table 9. Global Diabetic Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Diabetic Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Diabetic Therapeutic Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Diabetic Therapeutic Market Share by Regions (2016-2021) Table 13. Global Diabetic Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Diabetic Therapeutic Market Share by Regions (2022-2027) Table 15. Diabetic Therapeutic Market Trends Table 16. Diabetic Therapeutic Market Drivers Table 17. Diabetic Therapeutic Market Challenges Table 18. Diabetic Therapeutic Market Restraints Table 19. Global Diabetic Therapeutic Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Diabetic Therapeutic Market Share by Players (2016-2021) Table 21. Global Top Diabetic Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Therapeutic as of 2020) Table 22. Ranking of Global Top Diabetic Therapeutic Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Diabetic Therapeutic Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Diabetic Therapeutic Product Solution and Service Table 26. Date of Enter into Diabetic Therapeutic Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Diabetic Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 29. Global Diabetic Therapeutic Revenue Market Share by Type (2016-2021) Table 30. Global Diabetic Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Diabetic Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Diabetic Therapeutic Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Diabetic Therapeutic Revenue Market Share by Application (2016-2021) Table 34. Global Diabetic Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Diabetic Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Diabetic Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 37. North America Diabetic Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Diabetic Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 39. North America Diabetic Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Diabetic Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Diabetic Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Diabetic Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Diabetic Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Diabetic Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Diabetic Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Diabetic Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Diabetic Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Diabetic Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Diabetic Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Diabetic Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Diabetic Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Diabetic Therapeutic Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Diabetic Therapeutic Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Diabetic Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Diabetic Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Diabetic Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Diabetic Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Diabetic Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Diabetic Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Diabetic Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Diabetic Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Diabetic Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Diabetic Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Diabetic Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Diabetic Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 66. Sanofi Company Details Table 67. Sanofi Business Overview Table 68. Sanofi Diabetic Therapeutic Product Table 69. Sanofi Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 70. Sanofi Recent Development Table 71. Novo Nordisk Company Details Table 72. Novo Nordisk Business Overview Table 73. Novo Nordisk Diabetic Therapeutic Product Table 74. Novo Nordisk Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 75. Novo Nordisk Recent Development Table 76. MSD Company Details Table 77. MSD Business Overview Table 78. MSD Diabetic Therapeutic Product Table 79. MSD Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 80. MSD Recent Development Table 81. Astrazeneca Company Details Table 82. Astrazeneca Business Overview Table 83. Astrazeneca Diabetic Therapeutic Product Table 84. Astrazeneca Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 85. Astrazeneca Recent Development Table 86. Takeda Company Details Table 87. Takeda Business Overview Table 88. Takeda Diabetic Therapeutic Product Table 89. Takeda Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 90. Takeda Recent Development Table 91. Novartis Company Details Table 92. Novartis Business Overview Table 93. Novartis Diabetic Therapeutic Product Table 94. Novartis Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 95. Novartis Recent Development Table 96. AbbVie Company Details Table 97. AbbVie Business Overview Table 98. AbbVie Diabetic Therapeutic Product Table 99. AbbVie Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 100. AbbVie Recent Development Table 101. Eli Lilly Company Details Table 102. Eli Lilly Business Overview Table 103. Eli Lilly Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 104. Eli Lilly Recent Development Table 105. North China Pharmaceutical Group Corporation Company Details Table 106. North China Pharmaceutical Group Corporation Business Overview Table 107. North China Pharmaceutical Group Corporation Diabetic Therapeutic Product Table 108. North China Pharmaceutical Group Corporation Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 109. North China Pharmaceutical Group Corporation Recent Development Table 110. Huadong Medicine Company Details Table 111. Huadong Medicine Business Overview Table 112. Huadong Medicine Diabetic Therapeutic Product Table 113. Huadong Medicine Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 114. Huadong Medicine Recent Development Table 115. Dongbao Pharmaceutical Company Details Table 116. Dongbao Pharmaceutical Business Overview Table 117. Dongbao Pharmaceutical Diabetic Therapeutic Product Table 118. Dongbao Pharmaceutical Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 119. Dongbao Pharmaceutical Recent Development Table 120. Hisun Pharmacy Company Details Table 121. Hisun Pharmacy Business Overview Table 122. Hisun Pharmacy Diabetic Therapeutic Product Table 123. Hisun Pharmacy Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 124. Hisun Pharmacy Recent Development Table 125. KELUN Company Details Table 126. KELUN Business Overview Table 127. KELUN Diabetic Therapeutic Product Table 128. KELUN Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 129. KELUN Recent Development Table 130. Ginwa Company Details Table 131. Ginwa Business Overview Table 132. Ginwa Diabetic Therapeutic Product Table 133. Ginwa Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 134. Ginwa Recent Development Table 135. Tianan Pharmaceutical Company Details Table 136. Tianan Pharmaceutical Business Overview Table 137. Tianan Pharmaceutical Diabetic Therapeutic Product Table 138. Tianan Pharmaceutical Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 139. Tianan Pharmaceutical Recent Development Table 140. Jumpcan Pharmacy Company Details Table 141. Jumpcan Pharmacy Business Overview Table 142. Jumpcan Pharmacy Diabetic Therapeutic Product Table 143. Jumpcan Pharmacy Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 144. Jumpcan Pharmacy Recent Development Table 145. Guangzhou Baiyun Mountain Company Details Table 146. Guangzhou Baiyun Mountain Business Overview Table 147. Guangzhou Baiyun Mountain Diabetic Therapeutic Product Table 148. Guangzhou Baiyun Mountain Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 149. Guangzhou Baiyun Mountain Recent Development Table 150. SHIJIAZHUANG YILING PHARMACEUTICAL Company Details Table 151. SHIJIAZHUANG YILING PHARMACEUTICAL Business Overview Table 152. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetic Therapeutic Product Table 153. SHIJIAZHUANG YILING PHARMACEUTICAL Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 154. SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development Table 155. Wanbang Biopharmaceuticals Company Details Table 156. Wanbang Biopharmaceuticals Business Overview Table 157. Wanbang Biopharmaceuticals Diabetic Therapeutic Product Table 158. Wanbang Biopharmaceuticals Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 159. Wanbang Biopharmaceuticals Recent Development Table 160. Gan & Lee Company Details Table 161. Gan & Lee Business Overview Table 162. Gan & Lee Diabetic Therapeutic Product Table 163. Gan & Lee Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 164. Gan & Lee Recent Development Table 165. Taloph Company Details Table 166. Taloph Business Overview Table 167. Taloph Diabetic Therapeutic Product Table 168. Taloph Revenue in Diabetic Therapeutic Business (2016-2021) & (US$ Million) Table 169. Taloph Recent Development Table 170. Research Programs/Design for This Report Table 171. Key Data Information from Secondary Sources Table 172. Key Data Information from Primary Sources List of Figures Figure 1. Global Diabetic Therapeutic Market Share by Type: 2020 VS 2027 Figure 2. Sulphonylureas Features Figure 3. Biguanides Features Figure 4. Meglitinides Features Figure 5. Thiazolidinediones Features Figure 6. Alpha-glucosidase Inhibitors Features Figure 7. DPP-4 Inhibitors Features Figure 8. SGLT-2 Inhibitors Features Figure 9. Global Diabetic Therapeutic Market Share by Application: 2020 VS 2027 Figure 10. Diagnostic/Clinics Case Studies Figure 11. ICUs Case Studies Figure 12. Home Healthcare Case Studies Figure 13. Diabetic Therapeutic Report Years Considered Figure 14. Global Diabetic Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Diabetic Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Diabetic Therapeutic Market Share by Regions: 2020 VS 2027 Figure 17. Global Diabetic Therapeutic Market Share by Regions (2022-2027) Figure 18. Global Diabetic Therapeutic Market Share by Players in 2020 Figure 19. Global Top Diabetic Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Therapeutic as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Diabetic Therapeutic Revenue in 2020 Figure 21. Global Diabetic Therapeutic Revenue Market Share by Type (2016-2021) Figure 22. Global Diabetic Therapeutic Revenue Market Share by Type (2022-2027) Figure 23. North America Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Diabetic Therapeutic Market Share by Type (2016-2027) Figure 25. North America Diabetic Therapeutic Market Share by Application (2016-2027) Figure 26. North America Diabetic Therapeutic Market Share by Country (2016-2027) Figure 27. United States Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Diabetic Therapeutic Market Share by Type (2016-2027) Figure 31. Europe Diabetic Therapeutic Market Share by Application (2016-2027) Figure 32. Europe Diabetic Therapeutic Market Share by Country (2016-2027) Figure 33. Germany Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Diabetic Therapeutic Market Share by Type (2016-2027) Figure 41. Asia-Pacific Diabetic Therapeutic Market Share by Application (2016-2027) Figure 42. Asia-Pacific Diabetic Therapeutic Market Share by Region (2016-2027) Figure 43. China Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Diabetic Therapeutic Market Share by Type (2016-2027) Figure 51. Latin America Diabetic Therapeutic Market Share by Application (2016-2027) Figure 52. Latin America Diabetic Therapeutic Market Share by Country (2016-2027) Figure 53. Mexico Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Diabetic Therapeutic Market Share by Type (2016-2027) Figure 57. Middle East & Africa Diabetic Therapeutic Market Share by Application (2016-2027) Figure 58. Middle East & Africa Diabetic Therapeutic Market Share by Country (2016-2027) Figure 59. Turkey Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Diabetic Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Sanofi Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 63. Novo Nordisk Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 64. MSD Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 65. Astrazeneca Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 66. Takeda Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 67. Novartis Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 68. AbbVie Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 69. Eli Lilly Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 70. North China Pharmaceutical Group Corporation Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 71. Huadong Medicine Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 72. Dongbao Pharmaceutical Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 73. Hisun Pharmacy Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 74. KELUN Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 75. Ginwa Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 76. Tianan Pharmaceutical Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 77. Jumpcan Pharmacy Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 78. Guangzhou Baiyun Mountain Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 79. SHIJIAZHUANG YILING PHARMACEUTICAL Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 80. Wanbang Biopharmaceuticals Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 81. Gan & Lee Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 82. Taloph Revenue Growth Rate in Diabetic Therapeutic Business (2016-2021) Figure 83. Bottom-up and Top-down Approaches for This Report Figure 84. Data Triangulation Figure 85. Key Executives Interviewed

Sanofi Novo Nordisk MSD Astrazeneca Takeda Novartis AbbVie Eli Lilly North China Pharmaceutical Group Corporation Huadong Medicine Dongbao Pharmaceutical Hisun Pharmacy KELUN Ginwa Tianan Pharmaceutical Jumpcan Pharmacy Guangzhou Baiyun Mountain SHIJIAZHUANG YILING PHARMACEUTICAL Wanbang Biopharmaceuticals Gan & Lee Taloph